In Landmark Trial, Experimental Drug Delays Type 1 Diabetes

Credit: Wochit
Published on June 9, 2019 - Duration: 00:36s

In Landmark Trial, Experimental Drug Delays Type 1 Diabetes

In the culmination of a 33-year quest, scientists are reporting a milestone in type 1 diabetes: the first time the disease has been markedly delayed in young people at high risk.

According to Science Magazine, California researchers found that 2 weeks of an experimental intravenous drug held off disease by an average of about two years.

The mainstay of type 1 diabetes treatment is insulin, discovered 97 years ago.

Advertisement

You are here

You might like